Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial
暂无分享，去创建一个
H. Ohno | J. Kanda | T. Nakayama | K. Ueshima | A. Yonezawa | A. Takaori-Kondo | S. Tominari | Masayuki Kobayashi | K. Yamashita | K. Imada | Y. Ueda | T. Ishikawa | N. Arima | T. Kitano | T. Moriguchi | S. Yasuno | Mitsumasa Watanabe | N. Anzai | M. Nohgawa | Y. Kuwabara | Kayoko Nagata | M. Itoh | Masaaki Tsuji | T. Maeda | Hiroyuki Muranushi | Kohsuke Asagoe | H. Hirata | Hiromi Kitao | Ihhwa Kim | K. Kawagishi | Yoshihiro Kuwabara | Akihito Yonezawa